As a pharmacist for HCMC and Hennepin emergency services, Holly Drone has seen a lot. But when Drone described the pain of opiate withdrawal on patients, she turned to her clients’ and co-workers’ ...
Sparian Biosciences Inc. has been awarded a $19.5 million, 5-year grant to fund development of SBS-226 from IND submission through phase I development. SBS-226 is a first-in-class dual μ-opioid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback